Myeloma Steering Committee

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Myeloma Steering Committee (MYSC) was established in 2009.

Mission Statement

The MYSC follows an efficient, cost-effective, science-driven, and transparent process to identify and promote the "Best Science" in clinical research on myeloma and related diseases by addressing the design and prioritization of phase 3 trials and large phase 2 studies.

Roster of Myeloma Steering Committee (MYSC) members

MYSC Activities

Clinical Trials Planning Meetings (CTPMs)

CCCT Contact: Lawrence Baizer, Ph.D.